MarketCap
Facebook
X
TelegramQuarterly report 2025-Q2
added 07-30-2025
Guardant Health Operating Income 2011-2026 | GH
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Guardant Health
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -444 M | -565 M | -544 M | -411 M | -255 M | -82.4 M | -92.9 M | -76.6 M | -43.8 M | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -43.8 M | -565 M | -279 M |
Quarterly Operating Income Guardant Health
| 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -106 M | -111 M | - | -117 M | -101 M | -99.7 M | - | -114 M | -120 M | -134 M | - | -145 M | -130 M | -123 M | - | -107 M | -97.6 M | -108 M | - | -74.3 M | -54.6 M | -34.9 M | - | -17.5 M | -15.3 M | -23.7 M | - | -24.2 M | -22.7 M | -18.6 M | - | -28.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -15.3 M | -145 M | -80.3 M |
Operating Income of other stocks in the Diagnostics research industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
-46 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
-5 M | $ 21.01 | 8.92 % | $ 99.4 M |  Israel |
|
Akumin
AKU
|
-28.1 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Accelerate Diagnostics
AXDX
|
-14 M | - | -61.36 % | $ 2.46 M |  USA |
 |
Burning Rock Biotech Limited
BNR
|
-797 M | $ 22.01 | 11.81 % | $ 237 M |  China |
 |
Biocept
BIOC
|
-32 M | - | -13.05 % | $ 7.29 M | USA |
 |
Chembio Diagnostics
CEMI
|
-23.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
-42.7 M | $ 5.72 | 2.88 % | $ 168 M | USA |
 |
BioNano Genomics
BNGO
|
-104 M | $ 1.62 | 1.89 % | $ 2.06 M | USA |
 |
DarioHealth Corp.
DRIO
|
-56.2 M | $ 12.64 | 20.15 % | $ 359 M | Israel |
 |
DexCom
DXCM
|
598 M | $ 67.67 | 1.7 % | $ 26.1 B | USA |
 |
Castle Biosciences
CSTL
|
8.67 M | $ 38.51 | -0.08 % | $ 1.07 B | USA |
 |
Exact Sciences Corporation
EXAS
|
-876 M | $ 101.53 | -0.21 % | $ 18.8 B | USA |
 |
Danaher Corporation
DHR
|
4.86 B | $ 234.56 | 1.82 % | $ 171 B | USA |
 |
DermTech
DMTK
|
-104 M | - | -11.32 % | $ 2.94 M | USA |
 |
Fulgent Genetics
FLGT
|
-73.9 M | $ 25.48 | -0.43 % | $ 770 M | USA |
 |
Enzo Biochem
ENZ
|
-12.4 M | - | -8.98 % | $ 14.8 K | USA |
 |
Global Cord Blood Corporation
CO
|
609 M | - | - | $ 399 M | China |
 |
Genetron Holdings Limited
GTH
|
-518 M | - | 0.12 % | $ 80.1 M | China |
 |
CareDx, Inc
CDNA
|
-203 M | $ 20.02 | 4.6 % | $ 1.08 B | USA |
 |
Celcuity
CELC
|
-113 M | $ 104.43 | 3.86 % | $ 4.12 B | USA |
 |
Anixa Biosciences
ANIX
|
-13.8 M | $ 3.18 | 0.63 % | $ 101 K | USA |
 |
IQVIA Holdings
IQV
|
2.2 B | $ 233.99 | 3.82 % | $ 42.4 B | USA |
 |
Heska Corporation
HSKA
|
-20.3 M | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-20.8 M | - | -20.0 % | $ 1.06 M | USA |
 |
Aspira Women's Health
AWH
|
-32.8 M | - | -6.19 % | $ 10.5 M | USA |
 |
Illumina
ILMN
|
-833 M | $ 140.15 | 4.32 % | $ 22.3 B | USA |
 |
Charles River Laboratories International
CRL
|
227 M | $ 208.19 | 2.86 % | $ 10.7 B | USA |
 |
Myriad Genetics
MYGN
|
-124 M | $ 6.19 | 0.73 % | $ 561 M | USA |
 |
NeoGenomics
NEO
|
-92.1 M | $ 12.18 | 3.53 % | $ 1.54 B | USA |
 |
Neogen Corporation
NEOG
|
-1.06 B | $ 7.3 | 4.21 % | $ 1.58 B | USA |
 |
Natera
NTRA
|
-541 M | $ 235.89 | 3.08 % | $ 23.2 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
1.35 B | $ 173.85 | 0.13 % | $ 19.3 B | USA |
|
Biodesix
BDSX
|
-34.5 M | $ 6.05 | -6.35 % | $ 785 M | USA |
 |
OPKO Health
OPK
|
-152 M | $ 1.26 | -0.39 % | $ 874 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
1.09 B | $ 253.05 | 0.55 % | $ 21.2 B | USA |
 |
Motus GI Holdings
MOTS
|
-11.9 M | - | -34.28 % | $ 263 K | Israel |
 |
ICON Public Limited Company
ICLR
|
1.1 B | $ 197.18 | 4.51 % | $ 16.3 B |  Irlanda |
 |
IDEXX Laboratories
IDXX
|
1.13 B | $ 682.72 | 1.9 % | $ 56.3 B | USA |
 |
Lantheus Holdings
LNTH
|
457 M | $ 69.25 | 2.94 % | $ 4.79 B | USA |
 |
Pacific Biosciences of California
PACB
|
-334 M | $ 1.96 | 6.52 % | $ 497 M | USA |
 |
Agilent Technologies
A
|
1.35 B | $ 142.17 | 3.08 % | $ 43.2 B | USA |
 |
Organovo Holdings
ONVO
|
-12.6 M | - | -2.3 % | $ 19.4 M | USA |
 |
Biomerica
BMRA
|
-5.14 M | $ 2.56 | 1.19 % | $ 5.88 M | USA |